RECEPTOR-MEDIATED TOXICITY TO PERICYTES OF ADVANCED GLYCOSYLATION END-PRODUCTS - A POSSIBLE MECHANISM OF PERICYTE LOSS IN DIABETIC MICROANGIOPATHY

被引:133
作者
YAMAGISHI, SI
HSU, CC
TANIGUCHI, M
HARADA, SI
YAMAMOTO, Y
OHSAWA, KS
KOBAYASHI, KI
YAMAMOTO, H
机构
[1] KANAZAWA UNIV,SCH MED,DEPT BIOCHEM,KANAZAWA,ISHIKAWA 920,JAPAN
[2] KANAZAWA UNIV,SCH MED,DEPT INTERNAL MED 1,KANAZAWA,ISHIKAWA 920,JAPAN
[3] CHUNG SHAN MED & DENT COLL,TAICHUNG,TAIWAN
关键词
D O I
10.1006/bbrc.1995.2185
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The influence of advanced glycosylation end products (AGE) on bovine retinal pericytes was investigated. When pericytes were cultured with AGE-bovine serum albumin (BSA), pericyte growth was significantly retarded in a dose-dependent manner. They also exhibited an immediate toxicity to pericytes. However, MRC-5 human fibroblasts were totally resistant to AGE-BSA. Moreover, antisense oligonucleotides complementary to mRNA coding for AGE receptor were found to reverse the AGE-induced decrease in viable pericyte number, although the mRNA level was about one order of magnitude lower in pericytes than in the fibroblasts. These results indicate that pericytes may possess a peculiar sensitivity to AGE, and that AGE ligand-receptor interactions may play an important role in the pathogenesis of pericyte loss, the principal change in diabetic microangiopathies. (C) 1995 Academic Press, Inc.
引用
收藏
页码:681 / 687
页数:7
相关论文
共 21 条
[1]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[2]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[3]  
CHO HK, 1990, OPHTHALMIC SURG, V22, P44
[4]  
DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873
[5]  
DORCHY H, 1993, DIABETES CARE, V16, P1212, DOI 10.2337/diacare.16.8.1212
[6]   ENDOTHELIAL RECEPTOR-MEDIATED BINDING OF GLUCOSE-MODIFIED ALBUMIN IS ASSOCIATED WITH INCREASED MONOLAYER PERMEABILITY AND MODULATION OF CELL-SURFACE COAGULANT PROPERTIES [J].
ESPOSITO, C ;
GERLACH, H ;
BRETT, J ;
STERN, D ;
VLASSARA, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1387-1407
[7]   AMINOGUANIDINE TREATMENT INHIBITS THE DEVELOPMENT OF EXPERIMENTAL DIABETIC-RETINOPATHY [J].
HAMMES, HP ;
MARTIN, S ;
FEDERLIN, K ;
GEISEN, K ;
BROWNLEE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11555-11558
[8]  
HATAKEYAMA H, 1994, J BIOL CHEM, V269, P24316
[9]   FORTNIGHTLY REVIEW - DIABETIC-RETINOPATHY [J].
KOHNER, EM .
BRITISH MEDICAL JOURNAL, 1993, 307 (6913) :1195-1199
[10]   STUDIES OF RETINAL VASCULAR PATTERNS .1. NORMAL ARCHITECTURE [J].
KUWABARA, T ;
COGAN, DG .
ARCHIVES OF OPHTHALMOLOGY, 1960, 64 (06) :904-911